| 2025 |
DiaMedica Therapeutics Inc
|
Chairman of the Board |
- |
- |
| 2024 |
DiaMedica Therapeutics Inc
|
Chairman of the Board |
119.9 K |
32.0 % |
| 2024 |
Oncolytics Biotech, Inc.
|
Independent Director |
94.7 K |
30.4 % |
| 2022 |
DiaMedica Therapeutics Inc
|
Independent Director |
90.8 K |
-12.1 % |
| 2022 |
Oncolytics Biotech, Inc.
|
Independent Director |
72.6 K |
- |
| 2021 |
DiaMedica Therapeutics Inc
|
Independent Director |
103.3 K |
-2.1 % |
| 2020 |
DiaMedica Therapeutics Inc
|
Independent Director |
105.5 K |
26.5 % |
| 2019 |
DiaMedica Therapeutics Inc
|
Independent Director |
83.4 K |
100.5 % |
| 2018 |
DiaMedica Therapeutics Inc
|
Independent Director |
41.6 K |
16.8 % |
| 2017 |
DiaMedica Therapeutics Inc
|
Independent Director |
35.6 K |
- |